Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devices  by Morgan, Jeffrey A et al.
Brief
Communications
Effect of gender on bridging to transplantation and posttransplantation
survival in patients with left ventricular assist devices
Jeffrey A. Morgan, MD, Alan D. Weinberg, MS, Karen W. Hollingsworth, BS, Margaret R. Flannery, ANP,
Mehmet C. Oz, MD, and Yoshifumi Naka, MD, PhD, New York, NY
Studies have demonstrated sex differences in survival after various cardiac proce-dures, with superior survival for male over female patients.1 This might be due toa lower threshold to diagnose and aggressively treat heart disease in male patients,resulting in female patients presenting with more advanced pathology and systemic
manifestations.2 This study was designed to analyze our bridge-to-transplant experience since
the beginning of our program. Our primary goal was to determine the effect of sex on survival
while on support, rates of successful bridging to transplantation, and posttransplantation
survival.
Patients and Methods
We retrospectively reviewed our experience with Thoratec Heartmate assist devices from
August 1990 through September 2002. One hundred ninety-one (80.9%) male patients and 45
(19.1%) female patients underwent implantation. This included 52 pneumatic (40 male and
12 female patients), 17 dual-lead vented electric (15 male and 2 female patients), and 167
single-lead vented electric (136 male and 31 female patients) devices. Preimplantation left
ventricular assist device (LVAD) scores, determined on the basis of a patient’s presenting
degree of clinical stability and shown to correlate with survival on LVAD support in
multivariate analysis, were calculated for male and female patients.3 The study was per-
formed in accordance with institutional guidelines.
Data were represented as frequency distributions and percentages. Values of continuous
variables were expressed as means  SD. Continuous variables were compared by using
independent samples t tests, whereas categoric variables were compared by using 2 tests.
Kaplan-Meier analysis was used to calculate long-term survival. Significant predictors of
survival were identified by using multivariate Cox proportional hazard models. All data were
analyzed with SPSS 11.5 software.
Results
Demographics. Clinical characteristics of male and female patients are outlined in Table
1. There was no significant difference in age, race, or cause of heart failure (P  not
significant). Male patients had a significantly higher body surface area than female patients
(2.0  0.2 vs 1.8  0.2 kg/m2, P  .001). LVAD implantation scores were significantly
higher for female patients than male patients (6.4  3.1 vs 4.2  3.2, P  .020). Median
support time was similar between the groups (51.5 days [0-541 days] for male patients and
46.0 [0-397 days] for female patients, P  .412).
Survival on LVAD and transplantation rate. Survival on LVAD support was signifi-
cantly higher for male patients than for female patients (78.5% [n  150] vs 62.2% [n  28],
P  .022). Successful bridging to transplantation was also significantly higher for male
patients than for female patients (72.8% [n  139] vs 57.8% [n  26], P  .048).
Posttransplantation survival. Male patients demonstrated significantly improved post-
transplantation survival, with actuarial survival at 1, 3, and 5 years of 90.4%, 86.6%, and
85.2%, respectively, versus 87.8%, 74.3%, and 50.9%, respectively, for female patients (P 
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.010, Figure 1). However, when comparing male and female
patients with similar LVAD implantation scores, there was no
significant difference in survival (P  not significant).
Predictors of survival. For univariate analysis, significant pre-
dictors of survival included sex (P  .001), cause of heart failure
(P  .003 for idiopathic cardiomyopathy and P  .048 for other),
and LVAD score (P  .001), with a trend toward significance in
age (P  .080).
The only significant predictor of overall survival in multivariate
analysis was LVAD score (odds ratio, 1.214; 95% confidence
interval, 1.119-1.316; P .001). Patients with low LVAD implan-
tation scores (0-4) demonstrated improved survival over patients
with medium scores (5-7), whose survival was superior to that of
patients with high scores (8-10; P  .001). Sex was not an
independent predictor of survival (odds ratio, 0.724; 95% confi-
dence interval, 0.641-0.852; P  .124).
Discussion
In our study male patients demonstrated superior survival while
receiving mechanical assistance, a higher rate of successful bridg-
ing to transplantation, and improved survival after transplantation.
LVAD preimplantation scores were significantly higher for female
patients, indicating that female patients presented in a more ad-
vanced state of heart failure. This is consistent with studies that
have demonstrated a significant delay in the preliminary suspicion,
performance of diagnostic studies, and therapeutic intervention for
women with heart failure.4,5 The multivariate analysis supports the
notion that higher LVAD scores in female patients and not sex in
and of itself accounted for inequities in outcome between male and
female patients. Furthermore, after adjustment for LVAD score,
there was no significant difference in outcome between the sexes.
Additional evaluation of the causes for disproportionate survival
between male and female patients is warranted.
Limitations of this study include those related to a retrospec-
tively performed analysis. Data were obtained by means of chart
review, which is limited by access and accuracy of the data.
Additionally, data from our overall institutional experience were
TABLE 1. Clinical characteristics of male and female
LVAD recipients
Male
patients
Female
patients
P
value*
Mean age (y) 50.2 13.4† 47.1 15.3 .110
Race
White 147 (77.0%)‡ 33 (73.3%) .607
African American 28 (14.7%) 10 (22.2%) .214
Other 16 (8.4%) 2 (8.9%) .371
Cause
CAD 107 (56.0%) 27 (60.0%) .955
ICM 73 (38.2%) 15 (33.3%) .242
Other 11 (5.8%) 3 (6.7%) .326
BSA (kg/m2) 2.0 0.2 1.8 0.2 .001
LVAD score 6.4 3.1 4.2 3.2 .020
Infection
Drive line 15 (7.9%) 3 (6.7%) .781
Pocket 13 (6.8%) 3 (6.7%) .931
Pump 8 (4.2%) 2 (4.4%) .811
Any 36 (18.8%) 8 (17.8%) .947
In-flow regurgitation 5 (2.6%) 0 (0.0%) .173
CAD, Coronary artery disease; ICM, idiopathic cardiomyopathy; BSA, body
surface area.
*P value from independent samples t test.
†Mean  SD.
‡Absolute number (percentage).
Figure 1. Posttransplantation survival for male and female patients.
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evaluated, which included pneumatic, dual-lead vented electric,
and single-lead vented electric devices, although there have been
changes in criteria for device implantation, selection of candidates,
and the devices themselves. However, we pursued this approach
because of the relatively small number of patients in each individ-
ual device category and the lack of statistical power and because
the criteria for device implantation have always been similar for
male and female patients.
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Assessment of coronary flow reserve with a Doppler guide wire in
children with tetralogy of Fallot before and after surgical operation
Kentaro Toiyama, MD,a Isao Shiraishi, MD,a Tatsujiro Oka, MD,a Ayumi Kawakita, MD,a Naoya Iwasaki, MD,a
Toshikatsu Tanaka, MD,a Koichi Sakata, MD,a Toshiyuki Itoi, MD,a Keisuke Shuntoh, MD,b Masaaki Yamagishi, MD,b and
Kenji Hamaoka, MD,a Kyoto, Japan
Tetralogy of Fallot (TOF) is one of the most commoncyanotic congenital heart diseases in childhood. Beforesurgical repair, patients with TOF are exposed to rightventricular (RV) pressure overload, which induces RV
hypertrophy. Although cardiac hypertrophy has been shown to
induce impaired coronary microcirculation and cardiac dysfunc-
tion in adults,1 it is uncertain whether RV hypertrophy induces
impaired coronary microcirculation in patients with TOF. The
purpose of this study was to evaluate the relationship between the
RV pressure overload and the coronary flow reserve (CFR) in TOF
and to search for the best way to prevent life-threatening events.
Methods
The study population consisted of 14 patients with TOF (8 male
and 6 female, Table 1). They were divided into three groups:
preoperative (n  4), early postoperative (n  6), and late post-
operative (n  4). After the radical operation, the RV pressure of
these patients improved significantly. Echocardiographic examina-
tion after the surgical repair revealed mild to moderate pulmonary
regurgitation with mild RV dilatation. The control patients con-
sisted of 16 age-matched patients with Kawasaki disease who had
shown normal coronary arteries and normal ventricular function on
angiography.2,3 They were divided into two groups: younger than
6 years for the preoperative and the early postoperative groups and
6 to 16 years old for the late postoperative group. The Doppler
guide wire used in this study was a flexible, 0.018-inch guide wire
with a 12-MHz piezoelectric ultrasound transducer (FloWire; Car-
diometrics Inc, Mountain View, Calif). Blood flow velocity was
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TABLE 1. Patient characteristics
Groups
Preoperative
(n  4)
Early
postoperative
(n  6)
Late
postoperative
(n  4)
Age (y) 1.25 0.17 2.56 0.83 12.9 2.99
Sex (male/female) 2:2 2:4 4:0
RV pressure (mm Hg) 93.3 9.24 49.4 16.2* 53.0 11.4*
PA pressure (mm Hg) 14.7 5.7 20.7 4.0 20.3 7.8
RV-PA pressure
gradient (mm Hg)
78.7 9.23 26.2 18.1* 32.8 8.42*
Interval from
operation (y)
— 1.14 0.34 11.0 2.01
Pulmonary
insufficiency
—      
Data are presented as mean  SD. PA, Pulmonary artery; , slight
regurgitation; , mild regurgitation.
*P  .05 versus preoperative value.
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